Pfizer settles suit on Bextra marketing practices

Celebrex and Bextra lawsuits come to a close; Obama disses Fox; Toyota jumps into new campaign; and more

Pfizer reached a $894 million deal to end most of the lawsuits over Celebrex and Bextra, including claims by 33 states and the District of Columbia that Bextra was improperly promoted.

According to Reuters: "The charge includes $745 million to resolve personal injury claims, $60 million to settle with the states over Bextra marketing practices and $89 million to resolve consumer fraud class-action cases that allege Bextra and Celebrex promotions caused financial harm."

Bextra, a non-steroidal anti-inflammatory pain medication, was pulled from shelves in 2005 following claims of side effects like heart attacks and strokes.


Toyota announced plans for a $250 million marketing and sales campaign to encourage customers to come back to the showrooms and raise awareness among consumers that leasing and financing options are available.

Senator Barack Obama tells The New York Times that he'd be two, three points higher if there was no Fox News.

Tribune Co. may drop its service with the Associated Press, and would the largest newspaper chain to cut ties with the news cooperative.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in